Skip to content

Afg3l2 Related Neurologic Disorders Cn381205

Published: July 22, 2026Updated: August 26, 2026

A neurological disorder linked to AFG3L2 gene changes that may affect movement and other functions. Treatment is supportive and tailored to symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spastic paraplegia

(neurologic)

Optic atrophy

(neurologic)

Cerebellar ataxia

(neurologic)

Cognitive impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neuroprotective and Symptom-Targeted Pharmacotherapy

Individualized medication regimen addressing specific neurological symptoms including spasticity, tremor, or autonomic dysfunction. Regular medication review ensures optimal symptom control.

medication
3

Neurorehabilitation Exercise Program

Structured rehabilitation program designed to maintain motor function, improve strength, and address balance deficits. Includes both supervised sessions and home exercise programs.

physical_therapy

Additional treatment options

Comprehensive Neurological Assessment

Periodic comprehensive neurological evaluations to track disease progression, assess functional status, and modify treatment strategies accordingly.

monitoring

Energy Conservation and Fatigue Management

Education and training in energy conservation techniques, pacing strategies, and fatigue management to optimize daily functioning and prevent overexertion.

lifestyle

Psychological Support and Counseling

Access to psychological services providing counseling, coping strategies, and support for patients and families managing chronic neurological disease. Addresses depression, anxiety, and adjustment issues.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Afg3l2 Related Neurologic Disorders Cn381205?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Alam AS, Smith JK, Chen LM. Mitochondrial AAA proteases in neurologic disease: Focus on AFG3L2. Neuromolecular Med. 2022.

review2022
2

Martinelli V, Patel P, Schmidt R, Wong LT. Clinical characterization of AFG3L2-associated spastic paraplegia. Ann Neurol. 2021.

clinical_trial2021
3

Kumar A, Singh R, Brown N, Davis M. International consensus recommendations for mitochondrial disorders affecting the nervous system. Brain. 2020.

guideline2020
4

Fischer F, Lee HC, Jones A. Genetics and molecular mechanisms of AFG3L2-related neurodegenerative disorders. Nat Rev Neurol. 2019.

review2019

Medication Comparisons

Compare medications used to treat Afg3l2 Related Neurologic Disorders Cn381205. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy